Iridex Corp (IRIX)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Iridex Corp (IRIX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011029
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Iridex Corp (IRIDEX) is a medical device company that manufactures and distributes laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. The company provides products such as lasers, laser delivery devices, glaucoma devices, retinal surgical instruments, veterinary devices and delivery devices for the ophthalmology and otolaryngology markets. It provides laser products of different range and capacities. IRIDEX also offers laser delivery devices such as particle optics for optimal view and treatment. The company provides glaucoma devices such probes and lens. It offers retinal surgical instruments such as laser probes, consumables and dio-pexy probe. The company provides Fovea-friendly micro-pulse laser therapy to its customers. IRIDEX is headquartered in Mountain View, California, the US.

Iridex Corp (IRIX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Iridex Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Iridex Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Iridex Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Iridex Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Iridex Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Iridex Corp, Medical Equipment, Deal Details 10
Partnerships 10
Iridex Enters Into Licensing Agreement With Quantel Medical For MicroPulse 10
IRIDEX Enters Into Licensing Agreement With Alcon 11
IRIDEX Enters Into Licensing Agreement With Ocunetics 12
Icare Finland Enters into Distribution Agreement with Iridex 13
Iridex Enters Into Distribution Agreement With Peregrine Surgical 14
Equity Offering 15
Iridex Raises USD16 Million in Public Offering of Shares 15
Asset Transactions 17
Cutera Completes Acquisition Of Assets Of Aesthetic Business From IRIDEX For US$5.1 Million 17
Iridex Corp – Key Competitors 19
Iridex Corp – Key Employees 20
Iridex Corp – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Nov 02, 2017: IRIDEX Announces 2017 Third Quarter Financial Results 22
Aug 03, 2017: IRIDEX Announces 2017 Second Quarter, Six-Month Financial Results 24
May 03, 2017: IRIDEX Announces First Quarter 2017 Financial Results 25
Mar 08, 2017: IRIDEX Announces Fourth Quarter and 2016 Financial Results and Provides Full Year 2017 Financial Outlook 26
Jan 09, 2017: IRIDEX Announces Preliminary Unaudited Revenues for 2016 Fourth Quarter and Full Year 28
Nov 03, 2016: IRIDEX Reports 2016 Third Quarter, Nine-Month Results 29
Oct 11, 2016: IRIDEX Announces Preliminary Revenues for 2016 Third Quarter 30
Aug 04, 2016: IRIDEX Reports 2016 Second Quarter, Six-Month Results 31
May 05, 2016: IRIDEX Reports 2016 First Quarter Results 32
Mar 03, 2016: IRIDEX Reports 2015 Fourth Quarter, Full Year Results 33
Jan 11, 2016: IRIDEX Announces Preliminary Unaudited Revenues for 2015 Fourth Quarter and Full Year 34
Corporate Communications 35
Jul 18, 2017: IRIDEX Announces Appointment Of Ann Rhoads To Its Board Of Directors 35
Jul 11, 2016: IRIDEX Announces Atabak Mokari Will Be Chief Financial Officer And VP Corporate Development 36
Product News 37
May 04, 2017: IRIDEX Announces Presentation Of Data Demonstrating Safety And Efficacy Of Micropulse Technology At Upcoming Industry Conferences 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Iridex Corp, Medical Equipment, Key Facts, 2016 2
Iridex Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Iridex Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Iridex Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Iridex Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Iridex Corp, Deals By Market, 2011 to YTD 2017 8
Iridex Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Iridex Enters Into Licensing Agreement With Quantel Medical For MicroPulse 10
IRIDEX Enters Into Licensing Agreement With Alcon 11
IRIDEX Enters Into Licensing Agreement With Ocunetics 12
Icare Finland Enters into Distribution Agreement with Iridex 13
Iridex Enters Into Distribution Agreement With Peregrine Surgical 14
Iridex Raises USD16 Million in Public Offering of Shares 15
Cutera Completes Acquisition Of Assets Of Aesthetic Business From IRIDEX For US$5.1 Million 17
Iridex Corp, Key Competitors 19
Iridex Corp, Key Employees 20
Iridex Corp, Subsidiaries 21

★海外企業調査レポート[Iridex Corp (IRIX)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Martin Midstream Partners LP (MMLP):企業の財務・戦略的SWOT分析
    Martin Midstream Partners LP (MMLP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • RXi Pharmaceuticals Corporation:企業のM&A・事業提携・投資動向
    RXi Pharmaceuticals Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RXi Pharmaceuticals Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Vail Resorts Inc:戦略・SWOT・企業財務分析
    Vail Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Vail Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Virtusa Corp (VRTU):企業の財務・戦略的SWOT分析
    Virtusa Corp (VRTU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Tokyu Land Corporation:企業の戦略・SWOT・財務情報
    Tokyu Land Corporation - Strategy, SWOT and Corporate Finance Report Summary Tokyu Land Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Machavert Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Machavert Pharmaceuticals LLC (Machavert Pharmaceuticals) is a bio-pharmaceutical company which develops novel non-toxic medicines for the treatment of cancer and autoimmune diseases. Its lead drug candidate MP1000, a nanoparticulate liposomal phospholipid immune-modulating agent exhibits an …
  • Fluidigm Corp (FLDM)-医療機器分野:企業M&A・提携分析
    Summary Fluidigm Corp (Fluidigm) formerly known as Mycometrix Corporation, is a biotechnology company which manufactures life-science tools and creates technologies based on microfluidics and mass cytometry. The company’s products systems include biomark HD system, access array system, C1 system, ca …
  • Shanghai SECCO Petrochemical Co Ltd:企業の戦略的SWOT分析
    Shanghai SECCO Petrochemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Interpace Biosciences Inc (IDXG):企業の製品パイプライン分析
    Summary Interpace Biosciences Inc (Interpace Biosciences) formerly Interpace Diagnostics Group Inc, is a developer of molecular diagnostics tests. The company offers PancraGen, a DNA based molecular test that aids in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its pathf …
  • South Jersey Industries, Inc. (SJI):石油・ガス:M&Aディール及び事業提携情報
    Summary South Jersey Industries Inc (SJI) is an energy services holding company that sources and supplies natural gas and electricity. It develops, owns, and operates on-site energy production facilities. The company provides wholesale commodity marketing and fuel management services; and also offer …
  • Rio Tinto:企業のM&A・事業提携・投資動向
    Rio Tinto - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rio Tinto Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Dynegy Inc.:戦略・SWOT・企業財務分析
    Dynegy Inc. - Strategy, SWOT and Corporate Finance Report Summary Dynegy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • OpenHydro Group Limited:電力:M&Aディール及び事業提携情報
    Summary OpenHydro Group Limited (OpenHydro) a subsidiary of DCNS S.A. designs and manufactures marine turbines for generating renewable energy from tidal streams. The company offers installation and maintenance services for the construction of tidal farms using its Open-Centre Turbine technology. It …
  • Guangdong Carpoly Chemical Group Co Ltd:企業の戦略的SWOT分析
    Guangdong Carpoly Chemical Group Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Denny’s Corporation:戦略・SWOT・企業財務分析
    Denny's Corporation - Strategy, SWOT and Corporate Finance Report Summary Denny's Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Blackthorn Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Blackthorn Therapeutics Inc (Blackthorn Therapeutics) is a clinical stage biopharmaceutical company that discovers and develops targeted treatments for neurobehavioral disorders. The company offers products such as BTRX-246040, an NOPR antagonist; and BTRX-335140, a KOR antagonist. It uses I …
  • Fugro NV (FUR):電力:M&Aディール及び事業提携情報
    Summary Fugro NV (Fugro) is an integrated provider of geotechnical, survey, subsea and geosciences services. The company specializes in earth and engineering data services, from project preparation through to data acquisition, processing, analysis and interpretation, reporting and consulting. It ass …
  • Otto GmbH & Co KG:企業の戦略・SWOT・財務情報
    Otto GmbH & Co KG - Strategy, SWOT and Corporate Finance Report Summary Otto GmbH & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • JA Solar Holdings Co Ltd (JASO):企業の財務・戦略的SWOT分析
    JA Solar Holdings Co Ltd (JASO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • ArQule Inc (ARQL):製薬・医療:M&Aディール及び事業提携情報
    Summary ArQule Inc (ArQule) is a development stage clinical biotechnology company. It carries out discovery and development of next-generation, small molecule therapeutics for the treatment of various types of cancer. ArQule develops its oncology product candidates through novel approaches including …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆